• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病评估测试:系统评价。

The COPD assessment test: a systematic review.

机构信息

Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, McGill University, Montréal, QC, Canada Dept of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.

Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, McGill University, Montréal, QC, Canada.

出版信息

Eur Respir J. 2014 Oct;44(4):873-84. doi: 10.1183/09031936.00025214. Epub 2014 Jul 3.

DOI:10.1183/09031936.00025214
PMID:24993906
Abstract

The COPD assessment test (CAT) is a self-administered questionnaire that measures health-related quality of life. We aimed to systematically evaluate the literature for reliability, validity, responsiveness and minimum clinically important difference (MCID) of the CAT. Multiple databases were searched for studies analysing the psychometric properties of the CAT in adults with chronic obstructive pulmonary disease. Two reviewers independently screened, selected and extracted data, and assessed methodological quality of relevant studies using the COSMIN checklist. From 792 records identified, 36 studies were included. The number of participants ranged from 45 to 6469, mean age from 56 to 73 years, and mean forced expiratory volume in 1 s from 39% to 98% predicted. Internal consistency (reliability) was 0.85-0.98, and test-retest reliability was 0.80-0.96. Convergent and longitudinal validity using Pearson's correlation coefficient were: SGRQ-C 0.69-0.82 and 0.63, CCQ 0.68-0.78 and 0.60, and mMRC 0.29-0.61 and 0.20, respectively. Scores differed with GOLD stages, exacerbation and mMRC grades. Mean scores decreased with pulmonary rehabilitation (2.2-3 units) and increased at exacerbation onset (4.7 units). Only one study with adequate methodology reported an MCID of 2 units and 3.3-3.8 units using the anchor-based approach and distribution-based approach, respectively. Most studies had fair methodological quality. We conclude that the studies support the reliability and validity of the CAT and that the tool is responsive to interventions, although the MCID remains debatable.

摘要

COPD 评估测试(CAT)是一种自我管理的问卷,用于衡量与健康相关的生活质量。我们旨在系统地评估文献中 CAT 在慢性阻塞性肺疾病成人中的可靠性、有效性、反应性和最小临床重要差异(MCID)。对多个数据库进行了搜索,以寻找分析 CAT 心理测量特性的研究。两位审稿人独立筛选、选择和提取数据,并使用 COSMIN 清单评估相关研究的方法学质量。从确定的 792 条记录中,纳入了 36 项研究。参与者人数从 45 人到 6469 人不等,平均年龄从 56 岁到 73 岁,平均 1 秒用力呼气量从预测值的 39%到 98%不等。内部一致性(可靠性)为 0.85-0.98,重测信度为 0.80-0.96。使用 Pearson 相关系数的收敛性和纵向有效性分别为:SGRQ-C 为 0.69-0.82 和 0.63,CCQ 为 0.68-0.78 和 0.60,mMRC 为 0.29-0.61 和 0.20。评分与 GOLD 分期、加重期和 mMRC 分级不同。平均分数随着 GOLD 分期的升高而升高,随着 mMRC 分级的升高而降低。只有一项方法学质量较好的研究报告了 MCID 为 2 个单位,使用锚定方法和分布方法分别为 3.3-3.8 个单位。大多数研究的方法学质量为中等。我们得出结论,这些研究支持 CAT 的可靠性和有效性,并且该工具对干预措施有反应性,尽管 MCID 仍存在争议。

相似文献

1
The COPD assessment test: a systematic review.慢性阻塞性肺疾病评估测试:系统评价。
Eur Respir J. 2014 Oct;44(4):873-84. doi: 10.1183/09031936.00025214. Epub 2014 Jul 3.
2
Evaluating the Clinical COPD Questionnaire: A systematic review.评估临床慢性阻塞性肺疾病问卷:系统评价。
Respirology. 2017 Feb;22(2):251-262. doi: 10.1111/resp.12970.
3
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
4
Pulmonary rehabilitation for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的肺康复治疗
Cochrane Database Syst Rev. 2015 Feb 23;2015(2):CD003793. doi: 10.1002/14651858.CD003793.pub3.
5
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).吸气肌训练,联合或不联合肺康复治疗,用于慢性阻塞性肺疾病(COPD)。
Cochrane Database Syst Rev. 2023 Jan 6;1(1):CD013778. doi: 10.1002/14651858.CD013778.pub2.
6
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
7
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
8
Pulmonary rehabilitation versus usual care for adults with asthma.肺康复治疗与常规护理对哮喘成人的影响比较。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD013485. doi: 10.1002/14651858.CD013485.pub2.
9
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
10
Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.中重度慢性阻塞性肺疾病(COPD)患者的支持性自我管理:证据综合与经济分析
Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360.

引用本文的文献

1
Sex-Based Disparities in Clinical Burden and Diagnostic Delay in COPD: Insights from Primary Care.慢性阻塞性肺疾病临床负担和诊断延迟中的性别差异:来自初级保健的见解
J Clin Med. 2025 Sep 4;14(17):6258. doi: 10.3390/jcm14176258.
2
Non-invasive neuromodulation for alleviating dyspnoea: protocol for a feasibility sham-controlled randomised trial.用于缓解呼吸困难的非侵入性神经调节:一项可行性假对照随机试验的方案
BMJ Open. 2025 Jul 22;15(7):e103891. doi: 10.1136/bmjopen-2025-103891.
3
The Chronic Airways Assessment Test (CAAT™): Evolution From the COPD Assessment Test (CAT™).
慢性气道评估测试(CAAT™):从慢性阻塞性肺疾病评估测试(CAT™)演变而来。
Chronic Obstr Pulm Dis. 2025 May 27;12(3):203-206. doi: 10.15326/jcopdf.2025.0614.
4
(Pre-) atherosclerotic vessel changes in patients with chronic obstructive pulmonary disease and eosinophilia.慢性阻塞性肺疾病合并嗜酸性粒细胞增多患者的(前期)动脉粥样硬化血管改变。
BMC Pulm Med. 2025 Jun 2;25(1):277. doi: 10.1186/s12890-025-03720-y.
5
Immune, metabolic, anatomical, and functional features of people after successful tuberculosis treatment: an exploratory analysis.成功治疗结核病后人群的免疫、代谢、解剖及功能特征:一项探索性分析
Sci Rep. 2025 May 26;15(1):18392. doi: 10.1038/s41598-025-01656-1.
6
Leveraging Subjective Parameters and Biomarkers in Machine Learning Models: The Feasibility of for Managing Emphysema Progression.在机器学习模型中利用主观参数和生物标志物:管理肺气肿进展的可行性
Diagnostics (Basel). 2025 May 3;15(9):1165. doi: 10.3390/diagnostics15091165.
7
Digital gamification-based pursed lip breathing exercises driven by Behaviour Change Wheel in patients with COPD: a feasibility trial protocol using pre-post study design.基于行为改变轮的数字游戏化缩唇呼吸练习对慢性阻塞性肺疾病患者的影响:一项采用前后研究设计的可行性试验方案
BMJ Open. 2025 Mar 27;15(3):e090832. doi: 10.1136/bmjopen-2024-090832.
8
The Impact of Chronic Obstructive Pulmonary Disease Severity on Psychological and Functional Outcomes: A Cross-Sectional Analysis.慢性阻塞性肺疾病严重程度对心理和功能结局的影响:一项横断面分析。
J Clin Med. 2025 Mar 10;14(6):1865. doi: 10.3390/jcm14061865.
9
Using Text Messaging Ecological Momentary Assessment to Record Changes in e-Cigarette and Combustible Cigarette Use: Pilot Randomized Clinical Trial.使用短信生态瞬时评估记录电子烟和可燃香烟使用情况的变化:随机临床试验试点
JMIR Form Res. 2025 Mar 21;9:e66709. doi: 10.2196/66709.
10
THE EFFECT OF A SINGLE ORAL DOSE OF L-ARGININE ON QUADRICEPS STRENGTH IN SMOKERS AND NON-SMOKERS: A NON-RANDOMIZED CLINICAL TRIAL.单次口服 L-精氨酸对吸烟者和非吸烟者股四头肌力量的影响:一项非随机临床试验。
Acta Clin Croat. 2024 Oct;63(2):316-325. doi: 10.20471/acc.2024.63.02.7.